Response to MC Chamberlain: Convection-enhanced delivery of transforming growth factor-beta 2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to W Wick and M Weller: Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)

Bogdahn, Ulrich (2011) Response to MC Chamberlain: Convection-enhanced delivery of transforming growth factor-beta 2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to W Wick and M Weller: Trabedersen to target transforming growth factor-beta: when the journey is not the reward, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142). NEURO-ONCOLOGY, 13 (5). pp. 561-562. ISSN 1522-8517

Full text not available from this repository. (Request a copy)
Item Type: Article
Uncontrolled Keywords: PHASE-II; PROGNOSTIC-FACTORS; TEMOZOLOMIDE; TRIALS; PSEUDOPROGRESSION; PROCARBAZINE; THERAPY
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 02 Aug 2023 09:01
Last Modified: 02 Aug 2023 09:01
URI: https://pred.uni-regensburg.de/id/eprint/20847

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.